Smart insulin systems for kids: could early use change diabetes care?

This study looks at whether starting automated insulin delivery (AID) early in children aged 7–16 with type 1 diabetes improves blood sugar control, reduces stress for patients and families, and prevents long-term complications compared to standard insulin injections. One hundred children newly diagnosed will be randomly assigned to AID or injections and monitored for years. The goal is to see if the higher upfront cost of AID is worth it for better health outcomes.